• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Neoadjuvant in situ gene therapy with adenoviral delivery of HSV-tK gene for patients with high-risk prostate cancer

Research Project

Project/Area Number 21592060
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Urology
Research InstitutionKitasato University

Principal Investigator

SATOH Takefumi  北里大学, 医学部, 講師 (50286332)

Co-Investigator(Kenkyū-buntansha) BABA Shiro  北里大学, 医学部, 教授 (00051889)
MATSUMOTO Kazumasa  北里大学, 医学部, 講師 (70306603)
OKAYASU Isao  北里大学, 医学部, 教授 (20014342)
YANAGISAWA Nobuyuki  北里大学, 医学部, 講師 (80337914)
OBATA Fumiya  北里大学, 医療衛生学部, 教授 (60129236)
KUBU Makoto  北里大学, 医療衛生学部, 助教 (40464804)
TABATA Kenichi  北里大学, 医学部, 助教 (20327414)
Project Period (FY) 2009 – 2011
Project Status Completed (Fiscal Year 2011)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2011: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2010: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2009: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Keywords前立腺癌 / 遺伝子治療 / ネオアジュバント / ハイリスク群 / アデノウィルスベクター
Research Abstract

Neoadjuvant in situ cytotoxic gene therapy can potentially trigger a systemic immune response, which could impact occult micro-metastatic disease. We are currently conducting adenoviral vector mediated Herpes Simplex Virus-thymidine kinese(HSV-tk) gene plus ganciclovir(GCV) therapy as neoadjuvant intraprostatic injection for localized high-risk prostate cancer. This study evaluates the systemic T-cell response following gene therapy.
We enrolled 5 men with clinically localized prostate cancer but high risk for recurrence(Kattan nomogram score> 115) in this Phase I. II trial. Intraprostatic viral injections(two) were followed by 2 weeks of GCV and prostatectomy 4 weeks later.
A reduction in serum PSA was observed immediately after vector injection and GCV therapy in all patients. The mean reduction was 31.1% and ranged from 24.8 to 38.9%.
The pretreatment mean percentage of CD8+T cells positive for the HLA-DR marker of activation was 10.6%. For day 2, day 7, day 14, day 16 and day 56 post treatment, the mean percent of CD8+DR+T cells increased by 14.0%, 12.3%, 19.7%, 25.4% and 14.9%, which were statistically significant(day 14 ; p=0.0431, day 16 ; p=0.0431).
We present evidence of systemic T-cell responses following HSV-tk+GCV gene therapy under clinical trial condition. There was an increase in activated CD8+T cells in the peripheral blood following vector injection suggesting the potential for activation of components of cell-mediated immune response in this neoadjuvant setting.

Report

(4 results)
  • 2011 Annual Research Report   Final Research Report ( PDF )
  • 2010 Annual Research Report
  • 2009 Annual Research Report
  • Research Products

    (27 results)

All 2012 2011 2010 2009 2008

All Journal Article (8 results) (of which Peer Reviewed: 7 results) Presentation (19 results)

  • [Journal Article] A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin2011

    • Author(s)
      Kazumasa Matsumoto
    • Journal Title

      BJU INTERNATIONAL

      Volume: 108 Pages: 831-838

    • Related Report
      2011 Annual Research Report
    • Peer Reviewed
  • [Journal Article] ハイリスク前立腺癌に対する内分泌療法併用によるHDR brachytherapyの検討2010

    • Author(s)
      佐藤威文、石山博條, ほか12名
    • Journal Title

      泌尿器外科

      Volume: 23 Pages: 1181-1182

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] α1, 2-Fucosylated and β-N-acetylgalactosaminylated prostate specific antigen as an efficient marker of prostatic cancer.2010

    • Author(s)
      keiko Fukushima, Takefumi Satoh, ほか2名
    • Journal Title

      GLYCOBIOLOGY

      Volume: 20 Pages: 452-460

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy2010

    • Author(s)
      Kimura M, Mouraviev V, Tsivian M, Mayes JM, Satoh T, ほか1名
    • Journal Title

      British Journal of Urology International

      Volume: 105 Pages: 191-201

    • Related Report
      2010 Annual Research Report
    • Peer Reviewed
  • [Journal Article] L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer2009

    • Author(s)
      T Sakata, G Ferdous, T Tsuruta, T Satoh, et al
    • Journal Title

      PATHOLOGY INTERNATIONAL 59

      Pages: 7-18

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Single Infusion of Zoledronic Acid to Prevent Androgen Deprivation Therapy-induced Bone Loss in Men With Hormone-naive Prostate Carcinoma2009

    • Author(s)
      Takefumi Satoh
    • Journal Title

      CANCER 115

      Pages: 3468-3474

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Prostate-specific antigen'bounce' after permanent 1251-implant brachytherapy in Japanese Men : a multi-institutional pooled analysis.2009

    • Author(s)
      Takefumi Satoh
    • Journal Title

      BJU INTERNATIONAL 103

      Pages: 1064-1068

    • Related Report
      2009 Annual Research Report
    • Peer Reviewed
  • [Journal Article]2009

    • Author(s)
      佐藤威文
    • Journal Title

      Urology View(メジカルビュー社)

      Pages: 67-71

    • Related Report
      2009 Annual Research Report
  • [Presentation] Systemic T-cell activation following neoadjuvant in situ gene therapy in high-risk prostate cancer patients2012

    • Author(s)
      Satoh T, Kubo M, Tabata K, Kurosaka S, Matsumoto K, Fujita T, Obata F, Nasu Y, Kumon H, Kadmon D, Brenner MK, Thompson TC, Baba S
    • Organizer
      American Urological Association Annual Meeting
    • Place of Presentation
      Atlanta, USA
    • Year and Date
      2012-05-19
    • Related Report
      2011 Annual Research Report 2011 Final Research Report
  • [Presentation] Enhanced CD8+Tcell activation after in situ gene therapy of repeated HSV-tk injection andganciclovir administration in prostate cancer patients2011

    • Author(s)
      Kubo M, Satoh T, Tabata K, Matsumoto K, Baba S, Obata F
    • Organizer
      第40回日本免疫学会総会・学術集会
    • Place of Presentation
      幕張
    • Year and Date
      2011-11-27
    • Related Report
      2011 Final Research Report
  • [Presentation] mCRPCに対する治療戦略と課題2011

    • Author(s)
      佐藤威文
    • Organizer
      第49回日本癌治療学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-27
    • Related Report
      2011 Final Research Report
  • [Presentation] ハイリスク前立腺癌に対するネオアジュバントHSV-tk遺伝子治療の検討2011

    • Author(s)
      佐藤威文, 久保誠, 田畑健一, 黒坂眞二, 柳澤信之, 松本和将, 藤田哲夫, 佐藤絵里奈, 伊東一郎, 小幡文弥, 三枝信, 岡安勲, 那須保友, 公文裕巳, 馬場志郎
    • Organizer
      第49回日本癌治療学会学術集会
    • Place of Presentation
      名古屋
    • Year and Date
      2011-10-27
    • Related Report
      2011 Annual Research Report 2011 Final Research Report
  • [Presentation] 講演5:前立腺がんの転移・再発治療2011

    • Author(s)
      佐藤威文
    • Organizer
      第3回市民公開講座:前立腺がん治療の最前線「共に戦っていくための、今知っておくべき最新情報」
    • Place of Presentation
      有楽町朝日ホール(東京都、千代田区)(発表確定)
    • Year and Date
      2011-03-20
    • Related Report
      2010 Annual Research Report
  • [Presentation] 前立腺癌治療の最前線2011

    • Author(s)
      佐藤威文
    • Organizer
      第17回神奈川泌尿器科診療所懇話会
    • Place of Presentation
      横浜
    • Year and Date
      2011-02-26
    • Related Report
      2011 Final Research Report
  • [Presentation] Enhanced CD8+ Tcell activation after in situ gene therapy of repeated HSV-tk injection andganciclovir administration in prostate cancer patients2011

    • Author(s)
      Kubo M, Satoh T, Tabata K, Matsumoto K, Baba S, Obata F
    • Organizer
      第40回日本免疫学会総会・学術集会
    • Place of Presentation
      幕張
    • Related Report
      2011 Annual Research Report
  • [Presentation] mCRPC(転移・去勢抵抗性前立腺がん)に対する治療戦略と課題2010

    • Author(s)
      佐藤威文
    • Organizer
      第48回日本癌治療学会学術集会
    • Place of Presentation
      国立京都国際会館、グランドブリンスホテル京都(京都市)
    • Year and Date
      2010-10-28
    • Related Report
      2010 Annual Research Report
  • [Presentation] ホルモン抵抗性前立腺がん治療の現状と新たな展開:CRPCに対する遺伝子・細胞治療の現状と展開2010

    • Author(s)
      佐藤威文, ほか10名
    • Organizer
      第48回日本癌治療学会学術集会
    • Place of Presentation
      国立京都国際会館、グランドブリンスホテル京都(京都市)
    • Year and Date
      2010-10-28
    • Related Report
      2010 Annual Research Report
  • [Presentation] Immune responses in prostate cancer patients received in situ gene therapy of repeated HSV-tk injection and ganciclovir administration2010

    • Author(s)
      Kubo M, Satoh T, Tabata K, Matsumoto K, Baba S, Obata F
    • Organizer
      14th International Congress of Immunology
    • Place of Presentation
      Kobe
    • Year and Date
      2010-08-22
    • Related Report
      2011 Final Research Report
  • [Presentation] Immune responses in prostate cancer patients received in situ gene therapy of repeated HSV-tk injection and ganciclovir administration2010

    • Author(s)
      Kubo M, Satoh T, Tabata K, Matsumoto K, Baba S, Obata F
    • Organizer
      16th Japan Society of Gene Therapy
    • Place of Presentation
      Utsunomiya
    • Year and Date
      2010-07-01
    • Related Report
      2011 Final Research Report
  • [Presentation] Neoadjuvant In Situ Gene Therapy for Prostate Cancer : Kitasato Trial2010

    • Author(s)
      佐藤威文、久保誠、柳澤信之、田畑健一、松本和将、佐藤絵里奈、大草洋、岩村正嗣、小幡文弥、岡安勲、那須保友、公文裕巳、馬場志郎
    • Organizer
      平成21年度科学技術振興調整費国際共同研究の推進「アジア人の癌体質と遺伝子治療共同臨床研究」第3回国際研究者打合せ会
    • Place of Presentation
      岡山
    • Year and Date
      2010-03-04
    • Related Report
      2011 Final Research Report
  • [Presentation] The increase of activated CD8+T cells in prostate cancer patients received in situ gene therapy of repeated HSV-tk injection and ganciclovir administration2009

    • Author(s)
      Kubo M, Satoh T, Tabata K, Matsumoto K, Baba S, Obata F
    • Organizer
      第39回日本免疫学会総会・学術集会
    • Place of Presentation
      大阪
    • Year and Date
      2009-12-02
    • Related Report
      2011 Final Research Report
  • [Presentation] High Risk Prostate Cancerに対する治療戦略とマネージメント2009

    • Author(s)
      佐藤威文
    • Organizer
      第97回日本泌尿器科学会総会
    • Place of Presentation
      岡山コンベンションセンター(岡山)
    • Year and Date
      2009-04-17
    • Related Report
      2009 Annual Research Report
  • [Presentation] ハイリスク前立腺癌に対するネオアジュバント遺伝子治療の検討2009

    • Author(s)
      佐藤威文、久保誠、柳澤信之、田畑健一、松本和将、佐藤絵里奈、大草洋、岩村正嗣、小幡文弥、岡安勲、那須保友、公文裕巳、馬場志郎
    • Organizer
      第97回日本泌尿器科学会総会
    • Place of Presentation
      岡山
    • Year and Date
      2009-04-16
    • Related Report
      2011 Final Research Report
  • [Presentation] High Risk Prostate Cancerに対する治療戦略とマネージメント2009

    • Author(s)
      佐藤威文
    • Organizer
      第97回日本泌尿器科学会総会
    • Place of Presentation
      岡山
    • Year and Date
      2009-04-16
    • Related Report
      2011 Final Research Report
  • [Presentation] Neoadjuvant In Situ Gene Therapy for Prostate Cancer2009

    • Author(s)
      佐藤威文、久保誠、柳澤信之、田畑健一、松本和将、佐藤絵里奈、大草洋、岩村正嗣、小幡文弥、岡安勲、那須保友、公文裕巳、馬場志郎
    • Organizer
      平成20年度科学技術振興調整費国際共同研究の推進「アジア人の癌体質と遺伝子治療共同臨床研究第2回国際研究者打合せ会
    • Place of Presentation
      岡山
    • Year and Date
      2009-03-04
    • Related Report
      2011 Final Research Report
  • [Presentation] Immune responses in prostate cancer patients received in situ gene therapy of repeated HSV-tk injection and ganciclovir administration2008

    • Author(s)
      Kubo M, Satoh T, Tabata K, Matsumoto K, Baba S, Obata F
    • Organizer
      第38回日本免疫学会総会・学術集会
    • Place of Presentation
      京都
    • Year and Date
      2008-12-01
    • Related Report
      2011 Final Research Report
  • [Presentation] ハイリスク前立腺癌に対するHSV-tkネオアジュバント遺伝子治療2008

    • Author(s)
      佐藤威文、久保誠、柳澤信之、田畑健一、松本和将、佐藤絵里奈、大草洋、岩村正嗣、小幡文弥、岡安勲、那須保友、公文裕巳、馬場志郎
    • Organizer
      平成20年度科学技術振興調整費国際共同研究の推進「アジア人の癌体質と遺伝子治療共同臨床研究」第1回国際研究者会議
    • Place of Presentation
      岡山
    • Year and Date
      2008-06-07
    • Related Report
      2011 Final Research Report

URL: 

Published: 2009-04-01   Modified: 2017-10-13  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi